期刊文献+

急性非ST段抬高型心肌梗死患者合并心力衰竭的危险因素分析 被引量:10

Risk Factor Analysis of Heart Failure in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction
原文传递
导出
摘要 目的研究不同造影剂对急性非ST段抬高型心肌梗死(non-ST-segment elevation myocardial infarction,NSTEMI)患者经皮冠状动脉介入(percutaneous coronary intervention,PCI)术后心力衰竭的影响,探讨NSTEMI患者PCI术后心力衰竭的危险因素。方法入选375例行PCI术的NSTEMI患者,根据选用造影剂不同分为两组,碘克沙醇组(n=289)和碘海醇组(n=86),比较两组PCI术后心力衰竭发生率。采用多因素logistics逐步回归分析NSTEMI患者发生心力衰竭的危险因素。结果 (1)碘克沙醇组PCI术后心力衰竭发生率低于碘海醇组,但组间比较差异无统计学意义(P>0.05)。(2)多因素logistic回归分析显示,高敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)、2型糖尿病、年龄、高血压依次为NSTEMI患者PCI术后合并心力衰竭的危险因素(OR分别为2.234,1.942,1.017,1.738,P均<0.01)。结论不同造影剂对NSTEMI患者PCI术后合并心力衰竭无影响,在冠心病危险因素中,年龄、高血压病、2型糖尿病以及hs-CRP是NSTEMI患者合并心力衰竭的危险因素。 Objective To investigate the effects of different contrast agents on heart failure after percutaneous coronary intervention(PCI)in patients with non-ST-segment elevation myocardial infarction(NSTEMI),and explore the risk factors of heart failure in NSTEMI patients after PCI.Methods A total of 375 NSTEMI patients underwent PCI were divided into two groups according to the different use of contrast agent:iodixanol group(n=289)and iohexol group(n=86),the incidence of heart failure after PCI between two groups were analyzed and compared.The risk factors of heart failure in NSTEMI patients were analyzed by using multivariate logistics regression analysis.Results(1)The incidence of heart failure after PCI in the iodixanol group was lower than that in the iohexol group(P0.05).(2)Multivariate logistic regression(forward method)analysis showed that high-sensitivity C-reactive protein(hs-CRP),type 2 diabetes mellitus,age and hypertension were the risk factors for heart failure in NSTEMI patients after PCI(OR were 2.234,1.942,1.017,1.738,All P0.01).Conclusion Different contrast agents have no effect on heart failure in NSTEMI patients after PCI.Among the risk factors of coronary heart diseases,age,hypertension,type 2 diabetes and hs-CRP are the risk factors of NSTEMI complicated with heart failure.
作者 马军 彭毅 樊光辉 MA Jun;PENG Yi;FAN Guanghui(Graduate School, Hubei University of Chinese Medicine, Wuhan Hubei 430065, Chin)
出处 《华南国防医学杂志》 CAS 2018年第4期234-237,共4页 Military Medical Journal of South China
关键词 心力衰竭 急性非ST段抬高型心肌梗死 造影剂 logistics多因素回归分析 Heart failure Acute non-ST-segment elevation myocardial infarction Contrast agent Multivariatelogistics regression analysis
  • 相关文献

参考文献9

二级参考文献88

  • 1薛书峰,娄书花,赵建华,田利平,金军,马惠芳,王晓阳,褚雯.代谢综合征对急性心肌梗死近期预后的影响[J].临床心血管病杂志,2006,22(6):326-328. 被引量:11
  • 2慕朝伟,高润霖,陈纪林,杨跃进,乔树宾,姚民,秦学文,徐波,刘海波,吴永建,袁晋青,陈珏,李建军,戴军,尤士杰,窦克非,邱洪,王增武.非离子型碘造影剂的过敏样反应[J].中国循环杂志,2007,22(3):172-175. 被引量:44
  • 3Gibler WB,Cannon CP,Blomkalns AL,CharDM,Drew BJ,Hollander JE,et al; American Heart Association Council on Clinical Cardiology(Subcommittee on Acute Cardiac Care);Council on Cardiovascular Nursing,and Quality of Careand Outcomes Research Interdisciplinary Working Group; Society of Chest PainCenters.Practical implementation of the guidelines for unstable angina/non-ST-segmentelevation myocardial infarction in the ernergency department:a scientific statement fromthe American Heart Association Council on Clinical Cardiology (Subcommittee on AcuteCardiac Care),Council on Cardiovascular Nursing,and Quality of Care and Outcomes ResearchInterdisciplinary Working Group,in Collaboration with the Society of Chest PainCenters.Circulation 2005; 111:2699-2710.
  • 4Bertrand ME,Simoons ML,Fox KA,Wallentin LC,Hamm CW,McFadden E,et al; Task Force on theManagement of Acute Coronary Syndromes of the European Society of Cardiology.Management ofacute coronary syndromes in patients presenting without persistent ST-segmentelevation.Eur Heart J 2002; 23:1809-1840.
  • 5Braunwald E,Antman EM,Beasley JW,Califf RM,Cheitlin MD,Hochman JS,et al; AmericanCollege of Cardiology;American Heart Association.Committee on the Management of Patientswith Unstable Angina.ACC/AHA 2002 guideline update for the management of patients withunstable angina and non-ST-segment elevation myocardial infarction-summary article:areport of the American College of Cardiology/American Heart Association task force onpractice guidelines (Committee on the Management of Patients with Unstable Angina).J AmCoil Cardiol 2002; 40:1366-1374.
  • 6Bassand JP,Hamm CW,Ardissino D,Boersma E,Budaj A,Femández-Avilés F,etal.Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronarysyndromes.Eur Heart J 2007; 28:1598-1660.
  • 7Gore JM,Spencer FA,Goldberg RJ,Kennelly BM,Fox KA,Allegrone J,et al; GRACEInvestigators.Use of heparins in non-ST-elevation acute coronary syndromes.Am J Med2007;120:63-71.
  • 8Stiles MK,Dabbous OH,Fox KA; GRACE investigators.Bleeding events with antithrombotictherapy in patients with unstable angina or non-ST-segment elevation myocardialinfarction; insights from a large clinical practice registry (GRACE).Heart Lung Circ 2008;17:5-8.
  • 9Bolognese L,Falsini G,Liistro F,Angioli P,Ducci K,Taddei T,et al.Randomized comparisonof upstream tirofiban versus downstream high bolus dose tirofiban or abciximab ontissue-level perfusion and troponin release in high-risk acute coronary syndromes treatedwith percutaneous coronary interventions:the EVEREST trial.J Am Coll Cardiol 2006;47:522-528.
  • 10Glaser R,Glick HA,Herrmann HC,Kimmel SE.The role of risk stratification in the decisionto provide upstream versus selective glycoprotein Ⅱb/Ⅲa inhibitors for acute coronarysyndromes:a cost-effectiveness analysis.J Am Coil Cardiol 2006; 47:529-537.

共引文献909

同被引文献105

引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部